Condition: Alzheimer Dementia · Dementia · Alzheimer Dementia (AD) · Sponsor: Evan Thomas
To evaluate the safety and tolerability of low-dose whole brain radiotherapy (WBRT) delivered as an induction course of 0.3 Gy × 10 fractions (3.0 Gy total) followed by 12 months of monthly maintenance LDRT (0.3 Gy × 10 fractions; 3.0 Gy total) in patients with Alzheimer's disease or dementia with inflammatory components
This description comes directly from the study's public registry record.
Julia Pierson, BS · 321-972-1102 · jpierson@therenaissanceinstitute.org
Anita Stolaruk, RTT, MBA · 321-972-1102 · astolaruk@therenaissanceinstitute.org
Always discuss trial participation with your own doctor first.
| Renaissance Institute of Precision Oncology & Radiosurgery | Winter Park, Florida, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07693140